Ruxolitinib
Brand name: Jakavi
Ruxolitinib comes in 14 pill versions in our database, in 14 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Ruxolitinib pill images
5 mg 1 pill
5.0 mg 1 pill
10 mg 1 pill
10.0 mg 1 pill
11 mg 1 pill
15 mg 1 pill
- NVR L15 Ruxolitinib Phosphate 15 mg White, oval Used for polycythemia vera and primary myelofibrosis
15.0 mg 1 pill
20 mg 1 pill
20.0 mg 1 pill
22 mg 1 pill
25.0 mg 1 pill
33 mg 1 pill
44 mg 1 pill
55 mg 1 pill
What is Ruxolitinib used for?
Ruxolitinib is used for polycythemia vera and primary myelofibrosis.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Myelofibrosis
JAKAFI/JAKAFI XR is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF in adults.
Polycythemia Vera
JAKAFI/JAKAFI XR is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.
Acute Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older.
Chronic Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
From the FDA-approved label on DailyMed (published Aug 03, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.